Sign In
Buy LLY
$1,125.38
+42.15 (+3.89%)
At Close: Jun 04, 2026
BioPharma stocks face a potentially rocky 2024, analysts say
04:45pm, Wednesday, 03'rd Jan 2024
After a difficult 2023, biopharma investors won't necessarily have it any easier in 2024, analysts at UBS argued in a note to clients on Tuesday. “BioPharma investors will be happy to shut the doo
Why Eli Lilly Stock Is Jumping Today While the Overall Market Is Slumping
12:20pm, Wednesday, 03'rd Jan 2024
Early data points to Lilly's weight-loss drug Zepbound taking market share away from Ozempic and Wegovy. However, Novo Nordisk could still top Lilly in sales gains this year.
Missed Out on Eli Lilly? My Best Pharmaceutical Stock to Buy And Hold
11:08am, Wednesday, 03'rd Jan 2024
Eli Lilly's valuation sets a high bar for the stock. Its rival in the obesity space is a better deal and could be a better business.
Here is What to Know Beyond Why Eli Lilly and Company (LLY) is a Trending Stock
10:31am, Wednesday, 03'rd Jan 2024
Lilly (LLY) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Eli Lilly (LLY) Stock Up 57% in 2023: Will the Uptrend Continue?
09:46am, Tuesday, 02'nd Jan 2024
Lilly (LLY) is making rapid pipeline progress in areas like obesity, diabetes and Alzheimer's. Mounjaro and Zepbound are expected to be key top-line drivers for Lilly.
Profiting From Obesity Drugs HRTS, Novo Nordisk And Eli Lilly
06:12am, Tuesday, 02'nd Jan 2024
Spending on anti-obesity medication is increasing, with some individuals spending more on medication than on food. Novo Nordisk's semaglutide drug, sold as Wegovy, is in high demand and the company is
2024's Power Players: 7 Stocks Racing to a Trillion Valuation
08:56am, Monday, 01'st Jan 2024
As it stands now, six U.S.-listed stocks are in the “trillion dollar club,” or stocks with a market cap of at least $1 trillion. In the coming year, or in the years ahead, which other mega-cap s
Why Eli Lilly Stock Could Start Off 2024 With a Bang
07:15am, Monday, 01'st Jan 2024
The company's early Alzheimer's treatment, donanemab, may soon obtain approval from regulators. It has the potential to generate billions in revenue and may act as another growth catalyst for Lilly.
7 Investments To Avoid In 2024
07:00am, Monday, 01'st Jan 2024
7 Investments To Avoid In 2024
Why Is Eli Lilly Investing Up to $494 Million to Study Squirrel Hibernation?
09:00am, Sunday, 31'st Dec 2023
Eli Lilly is building a foundation for a strong position in the obesity treatment market. Squirrels that hibernate are effective at both gaining and shedding weight.
Eli Lilly Stock Jumped 59% in 2023. Is It a Good Stock to Buy in 2024?
05:36am, Sunday, 31'st Dec 2023
Soaring sales of diabetes drug Mounjaro made 2023 a great year to own Eli Lilly stock. Peak annual sales of recently-approved weight-management drug Zepbound (which has the same active ingredient as M
3 Ken Griffin Stocks to Invest Like Citadel
04:00pm, Saturday, 30'th Dec 2023
Ken Griffin is the founder, CEO and majority owner of Citadel, one of the premier hedge funds. Griffin founded the company in 1990 and grew it into what it is today through a combination of quantitati
Your New Year's Resolution For 2024: Invest $10,000 In These 5 Stocks
02:54pm, Friday, 29'th Dec 2023
I review the stocks of five world-class companies that I am convinced will bring me closer to my ambitious goal of being able to fund my living expenses through dividends.
Eli Lilly (LLY) Stock Declines While Market Improves: Some Information for Investors
06:48pm, Thursday, 28'th Dec 2023
The latest trading day saw Eli Lilly (LLY) settling at $580.85, representing a -0.11% change from its previous close.
Interested in the Weight-Loss Market? Here's 1 Stock to Buy Hand Over Fist in 2024, and 1 to Avoid Like the Plague.
08:30am, Thursday, 28'th Dec 2023
Eli Lilly is the developer of Mounjaro, a diabetes treatment generating billions in sales. Pfizer has had its challenges as it looks to enter the diabetes and obesity markets.
